Cargando…
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom
PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821285/ https://www.ncbi.nlm.nih.gov/pubmed/33091194 http://dx.doi.org/10.1002/pds.5150 |
_version_ | 1783639389268606976 |
---|---|
author | Arana, Alejandro Margulis, Andrea V Varas‐Lorenzo, Cristina Bui, Christine L Gilsenan, Alicia McQuay, Lisa J Reynolds, Maria Rebordosa, Cristina Franks, Billy de Vogel, Stefan Appenteng, Kwame Perez‐Gutthann, Susana |
author_facet | Arana, Alejandro Margulis, Andrea V Varas‐Lorenzo, Cristina Bui, Christine L Gilsenan, Alicia McQuay, Lisa J Reynolds, Maria Rebordosa, Cristina Franks, Billy de Vogel, Stefan Appenteng, Kwame Perez‐Gutthann, Susana |
author_sort | Arana, Alejandro |
collection | PubMed |
description | PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has not been thoroughly assessed in the United Kingdom Clinical Practice Research Datalink's (CPRD's) GOLD database. We explored the validity of algorithms to identify cardiovascular outcomes and risk factors and evaluated different outcome‐identification strategies using these algorithms for estimation of adjusted incidence rate ratios (IRRs). METHODS: First, we identified AMI, stroke, smoking, obesity, and menopausal status in a cohort treated for overactive bladder by applying computerized algorithms to primary care medical records (2004–2012). We validated these cardiovascular outcomes and risk factors with physician questionnaires (gold standard for this analysis). Second, we estimated IRRs for AMI and stroke using algorithm–identified and questionnaire–confirmed cases, comparing these with IRRs from cases identified through linkage with hospitalization/mortality data (best estimate). RESULTS: For AMI, the algorithm's positive predictive value (PPV) was >90%. Initial algorithms for stroke performed less well because of inclusion of codes for prevalent stroke; algorithm refinement increased PPV to 80% but decreased sensitivity by 20%. Algorithms for smoking and obesity were considered valid. IRRs based on questionnaire‐confirmed cases only were closer to IRRs estimated from hospitalization/mortality data than IRRs from algorithm‐identified cases. CONCLUSIONS: AMI, stroke, smoking, obesity, and postmenopausal status can be accurately identified in CPRD. Physician questionnaire–validated AMI and stroke cases yield IRRs closest to the best estimate. |
format | Online Article Text |
id | pubmed-7821285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78212852021-01-29 Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom Arana, Alejandro Margulis, Andrea V Varas‐Lorenzo, Cristina Bui, Christine L Gilsenan, Alicia McQuay, Lisa J Reynolds, Maria Rebordosa, Cristina Franks, Billy de Vogel, Stefan Appenteng, Kwame Perez‐Gutthann, Susana Pharmacoepidemiol Drug Saf Original Reports PURPOSE: Strategies to identify and validate acute myocardial infarction (AMI) and stroke in primary‐care electronic records may impact effect measures, but to an unknown extent. Additionally, the validity of cardiovascular risk factors that could act as confounders in studies on those endpoints has not been thoroughly assessed in the United Kingdom Clinical Practice Research Datalink's (CPRD's) GOLD database. We explored the validity of algorithms to identify cardiovascular outcomes and risk factors and evaluated different outcome‐identification strategies using these algorithms for estimation of adjusted incidence rate ratios (IRRs). METHODS: First, we identified AMI, stroke, smoking, obesity, and menopausal status in a cohort treated for overactive bladder by applying computerized algorithms to primary care medical records (2004–2012). We validated these cardiovascular outcomes and risk factors with physician questionnaires (gold standard for this analysis). Second, we estimated IRRs for AMI and stroke using algorithm–identified and questionnaire–confirmed cases, comparing these with IRRs from cases identified through linkage with hospitalization/mortality data (best estimate). RESULTS: For AMI, the algorithm's positive predictive value (PPV) was >90%. Initial algorithms for stroke performed less well because of inclusion of codes for prevalent stroke; algorithm refinement increased PPV to 80% but decreased sensitivity by 20%. Algorithms for smoking and obesity were considered valid. IRRs based on questionnaire‐confirmed cases only were closer to IRRs estimated from hospitalization/mortality data than IRRs from algorithm‐identified cases. CONCLUSIONS: AMI, stroke, smoking, obesity, and postmenopausal status can be accurately identified in CPRD. Physician questionnaire–validated AMI and stroke cases yield IRRs closest to the best estimate. John Wiley & Sons, Inc. 2020-10-28 2021-02 /pmc/articles/PMC7821285/ /pubmed/33091194 http://dx.doi.org/10.1002/pds.5150 Text en © 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Reports Arana, Alejandro Margulis, Andrea V Varas‐Lorenzo, Cristina Bui, Christine L Gilsenan, Alicia McQuay, Lisa J Reynolds, Maria Rebordosa, Cristina Franks, Billy de Vogel, Stefan Appenteng, Kwame Perez‐Gutthann, Susana Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom |
title | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom |
title_full | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom |
title_fullStr | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom |
title_full_unstemmed | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom |
title_short | Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom |
title_sort | validation of cardiovascular outcomes and risk factors in the clinical practice research datalink in the united kingdom |
topic | Original Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821285/ https://www.ncbi.nlm.nih.gov/pubmed/33091194 http://dx.doi.org/10.1002/pds.5150 |
work_keys_str_mv | AT aranaalejandro validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT margulisandreav validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT varaslorenzocristina validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT buichristinel validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT gilsenanalicia validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT mcquaylisaj validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT reynoldsmaria validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT rebordosacristina validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT franksbilly validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT devogelstefan validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT appentengkwame validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom AT perezgutthannsusana validationofcardiovascularoutcomesandriskfactorsintheclinicalpracticeresearchdatalinkintheunitedkingdom |